Trends in oncological imaging during the COVID-19 pandemic through the vaccination era.

BACKGROUND This study examines the impact that the COVID-19 pandemic has had on computed tomography (CT)-based oncologic imaging utilization. METHODS We retrospectively analyzed cancer-related CT scans during four time periods: pre-COVID (1/5/20-3/14/20), COVID peak (3/15/20-5/2/20), post-COVID peak (5/3/20-12/19/20), and vaccination period (12/20/20-10/30/21). We analyzed CTs by imaging indication, setting, and hospital type. Using percentage decrease computation and Student's t-test, we calculated the change in mean number of weekly cancer-related CTs for all periods compared to the baseline pre-COVID period. This study was performed at a single academic medical center and three affiliated hospitals. RESULTS During the COVID peak, mean CTs decreased (-43.0%, p < 0.001), with CTs for (1) cancer screening, (2) initial workup, (3) cancer follow-up, and (4) scheduled surveillance of previously treated cancer dropping by 81.8%, 56.3%, 31.7%, and 45.8%, respectively (p < 0.001). During the post-COVID peak period, cancer screenings and initial workup CTs did not return to prepandemic imaging volumes (-11.4%, p = 0.028; -20.9%, p = 0.024). The ED saw increases in weekly CTs compared to prepandemic levels (+31.9%, p = 0.008), driven by increases in cancer follow-up CTs (+56.3%, p < 0.001). In the vaccination period, cancer screening CTs did not recover to baseline (-13.5%, p = 0.002) and initial cancer workup CTs doubled (+100.0%, p < 0.001). The ED experienced increased cancer-related CTs (+75.9%, p < 0.001), driven by cancer follow-up CTs (+143.2%, p < 0.001) and initial workups (+46.9%, p = 0.007). CONCLUSIONS AND RELEVANCE The pandemic continues to impact cancer care. We observed significant declines in cancer screening CTs through the end of 2021. Concurrently, we observed a 2× increase in initial cancer workup CTs and a 2.4× increase in cancer follow-up CTs in the ED during the vaccination period, suggesting a boom of new cancers and more cancer examinations associated with emergency level acute care.

[1]  A. Jemal,et al.  Changes in Cancer Screening in the US During the COVID-19 Pandemic , 2022, JAMA network open.

[2]  Adel Elkbuli,et al.  Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations , 2022, The American surgeon.

[3]  A. Azuero,et al.  Examining the association among fear of COVID‐19, psychological distress, and delays in cancer care , 2021, Cancer medicine.

[4]  M. Gee,et al.  Trends in cancer imaging by indication, care setting, and hospital type during the COVID‐19 pandemic and recovery at four hospitals in Massachusetts , 2021, Cancer medicine.

[5]  D. Miglioretti,et al.  Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling , 2021, Journal of the National Cancer Institute.

[6]  M. Gee,et al.  Increased per-patient imaging utilization in an emergency department setting during COVID-19 , 2021, Clinical Imaging.

[7]  Matthew D. Li,et al.  Automated tracking of emergency department abdominal CT findings during the COVID-19 pandemic using natural language processing , 2021, The American Journal of Emergency Medicine.

[8]  B. Little,et al.  Google search volume trends for cancer screening terms during the COVID-19 pandemic , 2021, Journal of medical screening.

[9]  G. Luker,et al.  Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now , 2021, Radiology: Imaging Cancer.

[10]  Shimul A. Shah,et al.  Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer , 2020, Journal of the American College of Surgeons.

[11]  Ari B. Friedman,et al.  Disruptions in preventive care: Mammograms during the COVID-19 pandemic. , 2020, Health services research.

[12]  T. McLoud,et al.  Operational Challenges of a Low-Dose CT Lung Cancer Screening Program During the Coronavirus Disease 2019 Pandemic , 2020, Chest.

[13]  Phoebe E. Freer.  The Impact of the COVID-19 Pandemic on Breast Imaging , 2020, Radiologic Clinics of North America.

[14]  O. Pianykh,et al.  COVID-19: Recovery Models for Radiology Departments , 2020, Journal of the American College of Radiology.

[15]  O. Pianykh,et al.  Imaging Volume Trends and Recovery During the COVID-19 Pandemic: A Comparative Analysis Between a Large Urban Academic Hospital and Its Affiliated Imaging Centers , 2020, Academic Radiology.

[16]  C. Bender,et al.  COVID-19 Initial Impact on Radiology Practices: Survey from ACR/RBMA , 2020, Journal of the American College of Radiology.

[17]  M. Recht,et al.  Early-Stage Radiology Volume Effects and Considerations with the Coronavirus Disease 2019 (COVID-19) Pandemic: Adaptations, Risks, and Lessons Learned , 2020, Journal of the American College of Radiology.

[18]  C. Printz.  When a global pandemic complicates cancer care , 2020, Cancer.

[19]  D. Hughes,et al.  Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Imaging Case Volumes , 2020, Journal of the American College of Radiology.

[20]  I. Puzanov,et al.  COVID-19 and Cancer: a Comprehensive Review , 2020, Current Oncology Reports.

[21]  G. Luker,et al.  Transitioning to a New Normal after COVID-19: Preparing to Get Back on Track for Cancer Imaging , 2020, Radiology. Imaging cancer.

[22]  D. Shibata,et al.  Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations , 2020, Annals of Surgical Oncology.

[23]  M. Chua,et al.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.

[24]  M. Harrison,et al.  Emergency department visits for symptoms experienced by oncology patients: a systematic review , 2012, Supportive Care in Cancer.

[25]  R. Portenoy,et al.  A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. , 2002, The journal of pain : official journal of the American Pain Society.